1-17 of 17
Wei Jin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4041: Translational assessment of triple combination with Tislelizumab (anti-PD-1), LBL-007 (anti-LAG-3) and < for Surzebiclimab (anti-TIM-3) highlights its strong anti-tumor activity and < for clinical potential in solid tumors such as HNSCC

Hengrui Zhu, Jinhui Zhang, Han Yan, Xiao Ding, Juan Yang, Yu Jiang, Minjuan Deng, Haoxuan Song, Fangfang Ping, Fuyun Sun, Xiaoyu Li, Lijie Zhang, Bin Jiang, Weiwei Song, Zhirong Shen, Wei Jin, Jiyuan Zhang, Yun Zhang
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4041.
https://doi.org/10.1158/1538-7445.AM2024-4041
Published: 22 March 2024
View article titled, Abstract 4041: Translational assessment of triple combination with Tislelizumab (anti-PD-1), LBL-007 (anti-LAG-3) and &lt; for Surzebiclimab (anti-TIM-3) highlights its strong anti-tumor activity and &lt; for clinical potential in solid tumors such as HNSCC
Journal Articles

Abstract 741: Distinct functional effects of ILT family members in mediating the activity of an ILT2/ILT4/ILT5 cross-reactive monoclonal antibody in releasing the suppression on innate and adaptive anti-tumor immunity

Shiming Ye, Dong Zhang, Brenal Singh, Jaishree Bankoti, Diane Cohen, Siusze Tan, Donghee Choi, Jonathan Hickson, Min-Zu Wu, Urvi Kolhatkar, Mikhail Binnewies, Wei Jin, Jason Hall, John Engelhardt, Alexander Shoemaker
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 741.
https://doi.org/10.1158/1538-7445.AM2024-741
Published: 22 March 2024
View article titled, Abstract 741: Distinct functional effects of ILT family members in mediating the activity of an ILT2/ILT4/ILT5 cross-reactive monoclonal antibody in releasing the suppression on innate and adaptive anti-tumor immunity
Journal Articles

Abstract 6158: BGB-24714, a novel oral IAP antagonist, displayed significant anti-tumor activities in preclinical models as a monotherapy and in combination with paclitaxel

Jie Li, Nan Hu, Yilu Zhang, Xiaolong Yang, Minjuan Deng, Wenfeng Gong, Longbo Yin, Yong Liu, Yajuan Gao, Wei Wei, Xing Wang, Xinyi Liang, Yanwen Ma, Xuxing Sang, Chang Liu, Jingyuan Wang, Qianqian Lu, Fengtao Song, Xi Yuan, Yibing Wang, Jing Li, Wei Jin, Xuesong Liu, Xiaomin Song
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 6158.
https://doi.org/10.1158/1538-7445.AM2023-6158
Published: 04 April 2023
View article titled, Abstract 6158: BGB-24714, a novel oral IAP antagonist, displayed significant anti-tumor activities in preclinical models as a monotherapy and in combination with paclitaxel
Journal Articles

Abstract LB514: CD8 T cells and macrophage abundances associated with clinical benefit of tislelizumab in various tumor types

Wei Shen, Tengfei Liu, Yang Shi, Jingwen Shi, Dan Wang, Liang Liang, Silu Yang, Xiaopeng Ma, Wei Jin, Pei Zhang, Ruiqi Huang, Yun Zhang, Zhirong Shen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): LB514.
https://doi.org/10.1158/1538-7445.AM2022-LB514
Published: 15 June 2022
View article titled, Abstract LB514: CD8 T cells and macrophage abundances associated with clinical benefit of tislelizumab in various tumor types
Journal Articles

Abstract 5338: Pamiparib as a non-P-glycoprotein substrate PARP inhibitor can overcome ABCB1-mediated multidrug resistance in ovarian cancer cells

Minjuan Deng, Kang Qin, Yang Li, Yu Jiang, Wei Jin, Zhirong Shen
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5338.
https://doi.org/10.1158/1538-7445.AM2022-5338
Published: 15 June 2022
View article titled, Abstract 5338: Pamiparib as a non-P-glycoprotein substrate PARP inhibitor can overcome <em>ABCB1</em>-mediated multidrug resistance in ovarian cancer cells
Journal Articles

Abstract 920: Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics

Yi Pei, Thomas Pohl, Ahmed Hassan, Anna Przybyla, Raymond Yu, Huarui Lu, Fangqiang Tang, Kevin Chen, Wei Jin, Krizia Dominguez, Haichun Huang, Ming Lei, Zhong Liu, Han Li
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 920.
https://doi.org/10.1158/1538-7445.AM2021-920
Published: 01 July 2021
View article titled, Abstract 920: Harnessing multiple mechanisms of action to target Nectin-4 as anti-tumor therapeutics
Journal Articles

Abstract 1854: A Fc-competent anti-human TIGIT blocking antibody BGB-A1217 elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models

Xin Chen, Liu Xue, Xiao Ding, Qi Liu, Jing Zhang, Lei Jiang, Sha Liu, Hongjia Hou, Qing Zhu, Bin Jiang, Lijie Zhang, Xiaosui Zhou, Jie Ma, Yucheng Li, Wei Jin, Min Wei, Zhirong Shen, Mike Liu, Kang Li, Tong Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 1854.
https://doi.org/10.1158/1538-7445.AM2021-1854
Published: 01 July 2021
View article titled, Abstract 1854: A Fc-competent anti-human TIGIT blocking antibody BGB-A1217 elicits strong immune responses and potent anti-tumor efficacy in pre-clinical models
Journal Articles

Abstract A04: Targeting immunosuppressive alterations in the tumor microenvironment resulting from therapy-induced DNA damage responses

Wei Jin, Aric Zhao, Christine Levesque, Ilsa Colman, Peter S. Nelson
Journal: Cancer Research
Cancer Res (2016) 76 (15_Supplement): A04.
https://doi.org/10.1158/1538-7445.TME16-A04
Published: 28 July 2016
View article titled, Abstract A04: Targeting immunosuppressive alterations in the tumor microenvironment resulting from therapy-induced DNA damage responses
Journal Articles

SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling

Hong-Lin Jiang, He-Fen Sun, Shui-Ping Gao, Liang-Dong Li, Sheng Huang, Xin Hu, Sheng Liu, Jiong Wu, Zhi-Ming Shao, Wei Jin
Journal: Cancer Research
Series: Author Choice
Cancer Res (2016) 76 (4): 952–964.
https://doi.org/10.1158/0008-5472.CAN-15-1630
Published: 14 February 2016
View article titled, SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling
Open the PDF for SSBP1 Suppresses TGFβ-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling in another window
Includes: Supplementary data
Journal Articles

Abstract P1-07-18: Loss of Rab1B promotes triple-negative breast cancer metastasis by activating TGF-β/Smad signaling

HongLin Jiang, Hefen Sun, Wei Jin
Journal: Cancer Research
Cancer Res (2015) 75 (9_Supplement): P1-07-18.
https://doi.org/10.1158/1538-7445.SABCS14-P1-07-18
Published: 01 May 2015
View article titled, Abstract P1-07-18: Loss of Rab1B promotes triple-negative breast cancer metastasis by activating TGF-β/Smad signaling
Journal Articles

EMMPRIN (CD147) confers cancer cell resistance to anoikis through inhibition of bim induction

Jinming Yang, Peter O'neill, Wei Jin, Daniel J. Medina, Ramsey Foty, Mehnaaz Lomas, Greg M. Arndt, Yi Tang, Marian Nakada, Li Yan, William N. Hait
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 169.
Published: 15 April 2006
View article titled, EMMPRIN (CD147) confers cancer cell resistance to anoikis through inhibition of bim induction
Journal Articles

Evidence for transcriptional activation of the MDR1 gene by CtBP1 in human multidrug resistant cancer cells

Wei Jin, William N. Hait, Jin-Ming Yang
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 141.
Published: 15 April 2006
View article titled, Evidence for transcriptional activation of the <em>MDR1</em> gene by <em>CtBP1</em> in human multidrug resistant cancer cells
Journal Articles

Enhancer-Dependent Splicing of FGFR1 α-Exon Is Repressed by RNA Interference-Mediated Down-Regulation of SRp55

Wei Jin, Gilbert J. Cote
Journal: Cancer Research
Cancer Res (2004) 64 (24): 8901–8905.
https://doi.org/10.1158/0008-5472.CAN-04-0716
Published: 16 December 2004
View article titled, Enhancer-Dependent Splicing of <em>FGFR1</em> α-Exon Is Repressed by RNA Interference-Mediated Down-Regulation of SRp55
Open the PDF for Enhancer-Dependent Splicing of <em>FGFR1</em> α-Exon Is Repressed by RNA Interference-Mediated Down-Regulation of SRp55 in another window
Journal Articles

Alternative RNA processing of tumor suppressor gene CEACAM1 is correlated with over-expression of polypyrimidine tract-binding protein (PTB) in lung cancers

Liudi Yuan, Luo Wang, Wei Jin, Henning Ren, Ping Yue, Gilbert J. Cote, Li Mao
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 649–650.
Published: 01 April 2004
View article titled, Alternative RNA processing of tumor suppressor gene <em>CEACAM1</em> is correlated with over-expression of polypyrimidine tract-binding protein (PTB) in lung cancers
Journal Articles

Polypyrimidine Tract-Binding Protein Down-Regulates Fibroblast Growth Factor Receptor 1 α-Exon Inclusion

Wei Jin, Ivone G. Bruno, Tong-Xin Xie, Laura J. Sanger, Gilbert J. Cote
Journal: Cancer Research
Cancer Res (2003) 63 (19): 6154–6157.
Published: 14 October 2003
View article titled, Polypyrimidine Tract-Binding Protein Down-Regulates Fibroblast Growth Factor Receptor 1 α-Exon Inclusion
Open the PDF for Polypyrimidine Tract-Binding Protein Down-Regulates Fibroblast Growth Factor Receptor 1 α-Exon Inclusion in another window
Journal Articles

Fibroblast Growth Factor Receptor-1 α-Exon Exclusion and Polypyrimidine Tract-binding Protein in Glioblastoma Multiforme Tumors

Wei Jin, Ian E. McCutcheon, Gregory N. Fuller, Eileen S-C. Huang, Gilbert J. Cote
Journal: Cancer Research
Cancer Res (2000) 60 (5): 1221–1224.
Published: 01 March 2000
View article titled, Fibroblast Growth Factor Receptor-1 α-Exon Exclusion and Polypyrimidine Tract-binding Protein in Glioblastoma Multiforme Tumors
Open the PDF for Fibroblast Growth Factor Receptor-1 α-Exon Exclusion and Polypyrimidine Tract-binding Protein in Glioblastoma Multiforme Tumors in another window
Journal Articles

Glioblastoma Cell-specific Expression of Fibroblast Growth Factor Receptor-1β Requires an Intronic Repressor of RNA Splicing

Wei Jin, Weiqi Bi, Eileen S-C. Huang, Gilbert J. Cote
Journal: Cancer Research
Cancer Res (1999) 59 (2): 316–319.
Published: 15 January 1999
View article titled, Glioblastoma Cell-specific Expression of Fibroblast Growth Factor Receptor-1β Requires an Intronic Repressor of RNA Splicing
Open the PDF for Glioblastoma Cell-specific Expression of Fibroblast Growth Factor Receptor-1β Requires an Intronic Repressor of RNA Splicing in another window